The Company is a Korea-based company mainly engaged in the manufacturing and distribution of pharmaceuticals. The Company manufactures and sells specialty medicines through formulations such as solid dosage forms, liquid injections, and cefa powder injections. Major products include antibiotics such as kepodon injection and ceftazime injection 1g for the prevention and treatment of infectious diseases; musculoskeletal drugs for treating arthritis contains unihyal injection and galithio injection; circulatory system dugs for the treatment of cerebrovascular diseases, such as cacetile tab and limasta tab; as well as drugs for digestive system such as digestive disorders. In addition, the Company engaged in the contract manufacturing operation (CMO) business for other pharmaceutical companies. The Company distributes its products within domestic market and to overseas markets including Middle East, Southeast Asia and Latin America. The Company was established on August 10, 1985. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on July 26, 2018.
Headquarters
246, Munmakgongdan-Gil, Munmak-Eup, Wonju-Si, Gangwon-Do
Wonju; Gangwon;
Contact Details: Purchase the Union Korea Pharm Co.,Ltd. (Wonju) report to view the information.
Website: http://www.ukp.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service